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Long-chain n-6 and n-3 PUFA (LC-PUFA), arachidonic acid (AA) (20:4n-6) and DHA (22:6n-3), are critical
for optimal brain development. These fatty acids can be consumed directly from the diet, or synthesized
endogenously from precursor PUFA by Δ-5 (encoded by FADS1) and Δ-6 desaturases (encoded by
FADS2). The aim of this study was to determine the potential importance of maternal genetic variability
in FADS1 and FADS2 genes to maternal LC-PUFA status and infant neurodevelopment in populations with
high ﬁsh intakes. The Nutrition Cohorts 1 (NC1) and 2 (NC2) are longitudinal observational mother-child
cohorts in the Republic of Seychelles. Maternal serum LC-PUFA was measured at 28 weeks gestation and
genotyping for rs174537 (FADS1), rs174561 (FADS1), rs3834458 (FADS1-FADS2) and rs174575 (FADS2) was
performed in both cohorts. The children completed the Bayley Scales of Infant Development II (BSID-II) at
30 months in NC1 and at 20 months in NC2. Complete data were available for 221 and 1310 mothers from
NC1 and NC2 respectively. With increasing number of rs3834458 minor alleles, maternal concentrations
of AA were signiﬁcantly decreased (NC1 p¼0.004; NC2 po0.001) and precursor:product ratios for
linoleic acid (LA) (18:2n-6)-to-AA (NC1 po0.001; NC2 po0.001) and α-linolenic acid (ALA) (18:3n-3)-
to-DHA were increased (NC2 p¼0.028). There were no signiﬁcant associations between maternal FADS
genotype and BSID-II scores in either cohort. A trend for improved PDI was found among infants born to
mothers with the minor rs3834458 allele.In these high ﬁsh-eating cohorts, genetic variability in FADS
genes was associated with maternal AA status measured in serum and a subtle association of the FADS
genotype was found with neurodevelopment.
& 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
An adequate supply of long-chain PUFA (LC-PUFA) arachidonic
acid (AA) (20:4n-6) and DHA (22:6n-3) is critical for optimal brain
development [9]. The fetus relies entirely on the maternal supplyLtd. This is an open access article u
olenic acid; BSID-II, Bayley’s
; Δ6D, Δ6-desaturase; LA,
atty acids; MDI, Mental
Nutrition Cohort 2; PDI,
Child Development Study.
þ46 8336981.of these fatty acids in utero. These LC-PUFA can be obtained
directly from the diet, but can also be endogenously synthesized in
all mammalian systems from their essential n-6 and n-3 PUFA
precursors, linoleic acid (LA) (18:2n-6) and α-linolenic acid (ALA)
(18:3n-3) respectively. This synthesis involves a series of elonga-
tion and desaturation steps, catalyzed by the fatty acid desaturase
enzymes [34], where Δ-5 desaturase (Δ5D) and Δ-6 desaturase
(Δ6D) are recognized as rate-limiting enzymes [24] (Fig. 1).
However, the endogenous synthesis of LC-PUFA, particularly that
of DHA from ALA, is recognized to be extremely inefﬁcient [30].
For this reason consumption of preformed DHA from ﬁsh sources
is recommended.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. Pathways for endogenous n-6 and n-3 PUFA elongation and desaturation showing the activity of FADS1 and FADS2 and corresponding desaturation steps.
A.J. Yeates et al. / Prostaglandins, Leukotrienes and Essential Fatty Acids 102-103 (2015) 13–2014The FADS1 (encodingΔ5D) and FADS2 (encodingΔ6D) genes are
located head-to-head in a cluster on chromosome 11 (11q12-q13)
[8,20,31]. Carriers of certain genotypes in the FADS gene cluster
have consistently been shown to have higher biological status of
PUFA precursors, LA and ALA, and lower status of LC-PUFA products,
AA and EPA (20:5n-3), probably as a result of having lower
expression of the functional enzymes [14,16,19,26,29,42,7]. The
highest and the lowest proportion of variability, with respect to the
inﬂuence of FADS genes on PUFA composition, have been found for
AA and for DHA respectively [39].
Among cohorts of pregnant women, maternal genetic variation
in FADS has frequently been associated with lower concentrations
of AA and EPA in maternal blood and breast milk, as well as infant
blood [16,18,22,42]. Importantly, variation of the maternal FADS
genotype resulting in lower FADS1 and FADS2 activity has also
been associated with lower cognitive development of infants,
possibly owing to lower LC-PUFA status during critical stages of
fetal development [23,35,4].
These ﬁndings suggest that the FADS genotype may be an
important determinant not only of LC-PUFA status, but also of the
biological effects exerted by LC-PUFA. With respect to dietary
variation, it is not fully understood how dietary availability of LC-
PUFA impacts on the association between FADS genotype and LC-
PUFA status [12]. It has been suggested that FADS genotype may be
a greater determinant of LC-PUFA status in populations where ﬁsh
consumption is low and there is expected to be greater depen-
dence on endogenous synthesis of LC-PUFA [32]. Yet there remain
no data on the inﬂuence of FADS genotype, on either LC-PUFA
status or neurodevelopment, in populations with high ﬁsh con-
sumption. These data would be important for risk assessment byproviding further evidence on the risks and beneﬁts of ﬁsh con-
sumption during pregnancy.
The objective of the current study was to characterize mothers
in two high ﬁsh-eating cohorts of the Seychelles Child Develop-
ment Study (SCDS) for FADS1 and FADS2 and to investigate asso-
ciations among maternal genotype, LC-PUFA status and develop-
mental outcomes of their infants. It was hypothesized that
mothers with minor alleles of SNPs in either FADS1 or FADS2
would have higher blood concentrations of precursor n-6 and n-3
PUFA, LA and ALA, and lower concentrations of LC-PUFA products,
AA and DHA. We further hypothesized that such variation in the
maternal status of these PUFA during pregnancy could impact the
cognitive development of their children.2. Methods
2.1. Study population
The SCDS is a longitudinal observational study conducted in the
Republic of Seychelles, an archipelago in the Indian Ocean. The
population resides mainly on the island of Mahé and is of mixed
African, European and East Asian origin. The overall aim of the
SCDS is to investigate the effects of methyl mercury (MeHg) and
nutrient exposure, from maternal ﬁsh consumption during preg-
nancy, on child developmental outcomes. The study has found no
consistent pattern of adverse associations of prenatal MeHg
exposure and neurodevelopment in children of mothers consum-
ing an average of 12 ﬁsh meals per week [33,38,40].
Apparently healthy mothers were recruited to Nutrition Cohort
1 (NC1) and Nutrition Cohort 2 (NC2) during their ﬁrst antenatal
A.J. Yeates et al. / Prostaglandins, Leukotrienes and Essential Fatty Acids 102-103 (2015) 13–20 15visit (from 14 weeks of gestation) at eight health centers across
Mahé. NC1 mothers were recruited in 2001 until 300 volunteers
had consented [5], and NC2 mothers were enrolled from 2008
until 2011 when the target number of 1500 mothers had con-
sented [38]. Further information on inclusion criteria and power
calculations for NC1 [36] and NC2 have previously been described
[38]. In NC1, mothers completed a 4-day food diary at 28 weeks
gestation to estimate their average daily consumption of ﬁsh [3]. In
NC2, mothers completed a retrospective Fish Use Questionnaire,
also at 28 weeks gestation, to estimate their weekly consumption
of ﬁsh during pregnancy. This study was conducted according to
guidelines laid down in the Declaration of Helsinki and all study
procedures involving participants were reviewed and approved by
the Seychelles Ethics Board, the Research Subjects Review Board at
the University of Rochester, and the Regional Ethics Committee at
Lund University, Sweden.
2.2. Blood sampling and analyses
At 28 weeks gestation non-fasting blood samples were collected
in both cohorts and serum and whole blood were obtained after
processing at the Public Health Laboratory of the Ministry of Health.
Maternal serum samples were shipped at 80 °C to the University
of Ulster where they were analyzed for fatty acid concentrations.
Total lipids were extracted and fatty acid methyl esters (FAME) were
prepared by boron triﬂuroide methanol (BF3) according to an
adaptation of the Folch method [6]. FAME were detected and
quantiﬁed using the gold-standard technique of Gas Chromato-
graphy–Mass Spectrometry (GC–MS) (Agilent 7890A-5975C, UK)
using heptadecaenoic acid (C17:0) as the internal standard, as pre-
viously described [36]. All analytical standards were of 499% purity
and purchased from Sigma-Aldrich, UK. Total serum PUFA compo-
sition is presented as mg/ml to indicate physiological quantities. In
NC1, there were 11 women missing 28 week PUFA status, but values
for these women were imputed from PUFA concentrations which
were also measured at delivery in the NC1 cohort [5]. As described
previously, the efﬁciency of blood processing in the Seychelles was
improved in NC2 compared to NC1 [37].
2.3. Genotyping
Maternal whole blood samples were shipped at 80 °C to the
University of Lund, Sweden for genotyping. Four candidate SNPs:
FADS1 rs174537 and rs174561, FADS1-FADS2 rs3834458 and FADS2
rs174575; were selected based on evidence of impacting on LC-PUFA
in epidemiological studies (Online Resource 1). The rs3834458 is
located in the promoter of FADS2 and 50 of FADS1 and is often
referred as intergenic [22]. DNA was extracted from maternal blood
using the Qiagen DNA Blood Mini kit (Qiagen, Hilden, Germany).
SNPs were genotyped by using the iPLEXs Gold assay on the Mas-
sARRAY platform (SequenomTM, San Diego, USA) and by TaqMan
allelic discrimination assay on an ABI 7900 instrument (Applied
Biosystems, Foster City, CA, USA), according to the manufacturer's
instructions. A random selection of the samples were re-analyzed for
quality control purposes with perfect agreement between original
and repeat genotyping runs for all SNPs. Mother's DNA samples
missing more than two of the ﬁve SNPs recorded in each genotyping
batch were considered unreliable and not included in the database,
whilst those missing less than two of all SNPs were included. These
differences in genotyping efﬁciency account for different sample
sizes for each SNP measured.
2.4. Developmental assessment
When infants were aged approximately 30 months in NC1 and
20 months in NC2, they completed developmental testing with theBayley Scales of Infant Development (BSID-II). Testing was con-
ducted by specially trained nurses at the Child Development
Centre, Mahé. All study forms were shipped to the University of
Rochester, where data were double-entered and the Mental
Development Index (MDI) and Psychomotor Development Index
(PDI) endpoints were scaled according to the child’s age at testing.
Test reliabilities for the BSID-II were determined as previously
described [36].
2.5. Statistical analyses
Deviations from Hardy–Weinberg equilibrium were tested
using chi-square analysis. One SNP (rs174561) was in Hardy
Weinberg disequilibrium in both populations (Online Resource 2).
As this SNP was genotyped with two different methods (NC1 with
Sequenom and NC2 with Taqman) and there was a perfect match
between re-runs, we considered the genotyping results correct.
Linkage disequilibrium was evaluated using Haploview [2]. Tests
for associations between outcomes and SNPs were carried out
from a priori analysis plans and all effects were tested using two-
sided tests of signiﬁcance at the α¼ 0.05 level. Unadjusted linear
regression was used to estimate the effect of each of the four FADS
SNPs on each of the eight individual LC-PUFA measurements and
on the precursor:product ratios, LA:AA, ALA:EPA and ALA:DHA.
The ratios of LA:AA and ALA:EPA are commonly used as crude
indicators of desaturase activity [41]. The minor allele frequencies
were sufﬁciently large in each of these SNPs that heterozygote and
variant homozygote effects were estimated separately. In order to
make the LC-PUFA results more comparable, we scaled maternal
serum PUFA composition in each cohort using homozygote car-
riers of the common SNP as a reference and the relative differences
are presented [27,28].
Multiple linear regression was used to estimate the effect of
FADS SNPs on the child's neurodevelopment, measured as BSID-II
scores. Adjustments were made for covariates previously chosen to
cover the most important determinants of neurocognitive devel-
opment in children [36]. These include child sex, maternal age at
delivery, presence of two parents in the household, socioeconomic
score, and birth weight (NC1) or child age at testing (NC2).
The children in the NC2 cohort were tested approximately 10
months before the age at which testing of NC1 children took place.
Over the course of the SCDS, we have observed that the mean
scaled score within each cohort decreased with age when followed
longitudinally. To make the results more comparable between
cohorts, we scaled the BSID-II scores in each cohort by using
estimated mean scores in homozygote carriers of the common SNP
as a reference and the relative differences are presented.3. Results
A total of n¼222 NC1 mothers and n¼1400 NC2 mothers were
included in the current study after exclusions owing to missing
data in developmental outcomes, LC-PUFA, SNPs and covariates.
Descriptive characteristics of the two cohorts, including covariate
data, are presented in Table 1. The LC-PUFA values differed
between the cohorts and were, apart from LA, generally higher in
NC2. This ﬁnding may be as a result of potential oxidation of
samples during blood processing in NC1, as previously described
[37]. NC1 mothers consumed on average 9 ﬁsh meals per week
[36], whereas NC2 mothers consumed an average of 8.5 estimated
ﬁsh servings per week [38].
The genotype distributions in NC1 and NC2 are presented in
Table 2. The allele frequencies for the FADS SNPs were similar
between the Seychellois cohorts (Online Resource 2). For all SNPs,
the minor allele frequencies were lower in the Seychellois
A.J. Yeates et al. / Prostaglandins, Leukotrienes and Essential Fatty Acids 102-103 (2015) 13–2016populations compared to European and African populations [10].
FADS2 rs174575 was found not to be in linkage disequilibrium (LD)
with any of the other SNPs, whereas the other three SNPs (FADS1
rs174561 and rs174537, FADS1-FADS2 intergenic rs3834458) had
pairwise LD values ranging from 0.83 to 0.93 (data not shown).
Therefore, the following results are presented for rs174575 (not in
strong LD with other SNPs) and rs3834458 (in strong LD with
rs174561 and rs174537). Results for the other SNPs in LD with
rs3834458 are presented in Online Resources 3 and 4.
Genetic associations with maternal PUFA composition were
evaluated as shown in Table 3. There was a signiﬁcant association
between rs3834458 and serum composition of AA and the ratio of
LA:AA in both cohorts. With increasing number of variant alleles,
the relative concentrations of AA were reduced in both cohorts
(NC2 po0.001; NC1 p¼ 0.004). The magnitude of association was
somewhat larger in NC2 where rs3834458 deldel carriers showed
20% lower AA than TT carriers, compared to 16.5% lower AA shown
in NC1 deldel carriers (Fig. 2). The association with the LA:AA ratioTable 1
Summary statistics for the NC1 and NC2 cohortsa,b,c.
NC1 NC2
n Mean SD n Mean SD
Maternal Serum PUFA composition (mg/ml)
LA 222 1.170 0.219 1399 0.898 0.252
AA 222 0.101 0.022 1399 0.202 0.081
ALA 222 0.002 0.001 1399 0.037 0.006
EPA 222 0.031 0.009 1399 0.183 0.084
DHA 222 0.003 0.002 1399 0.052 0.008
BSID-II
MDI 221 84.97 9.59 1358 87.71 10.69
PDI 218 89.80 13.78 1356 96.78 10.58
Demographics
Maternal age (yr) 222 27.7 6.0 1400 27.0 6.3
Maternal BMI (kg/m2) 221 25.8 6.4 1291 26.9 6.5
Hollingshead SES 222 33.9 11.1 1353 32.0 10.3
Girls (% in cohort) 222 51.4 – 1401 48.0 –
Parents at home (% in cohort) 221 42.1 – 1353 72.5 –
Child birth weight (g) 222 3232.2 470.4 1393 3178.8 498.3
Maternal ﬁsh consumption
(meals/week)
221 9.1 4.1 1321 8.5 4.6
a NC1, Nutrition Cohort 1; NC2, Nutrition Cohort 2; LA, linoleic acid; AA, ara-
chidonic acid; ALA, α-linolenic acid; BSID-II, Bayley Scales of Infant Development II;
MDI, Mental Developmental Index; PDI, Psychomotor Developmental Index; Hol-
lingshead SES, socioeconomic status.
b Data shown are for all models.
c BSID-II scores are from 30 mo assessment in NC1 and 20 mo assessment
in NC2.
Table 2
Genotype distribution in NC1 and NC2 mothersa,b,c.
SNP N genotyped Reference hom
NC1
FADS1 rs174537 180 63.3 GG
FADS1 rs174561 193 77.2 TT
FADS1-FADS2 rs3834458 220 65.9 TT
FADS2 rs174575 214 59.8 CC
NC2
FADS1 rs174537 1413 67.9 GG
FADS1 rs174561 1413 72.1 TT
FADS1-FADS2 rs3834458 1414 70.4 TT
FADS2 rs174575 1413 61.2 CC
a NC1, Nutrition Cohort 1; NC2, Nutrition Cohort 2; del¼one base-pair deletion.
b n¼180–220 in NC1 and n¼1413–1414 in NC2 depending on genotyping efﬁciency
c rs3834458 is FADS1-FADS2 intergenic [25].was as expected, with ratios being signiﬁcantly higher with
increasing number of variant alleles (NC2 po0.001; NC1
po0.001). In the larger NC2 cohort further associations between
rs3834458 and PUFA status were found with variant carriers
having signiﬁcantly higher LA (p¼0.002) and ALA (p¼0.017)
concentrations and signiﬁcantly different ratios of ALA:DHA
(p¼0.028, all 2 df tests). For ALA:DHA, deldel carriers had a 24.4%
higher ratio compared to TT carriers. The results were very similar
for the two other SNPs in LD with rs3834458 (Fig. 2).
In NC1, rs174575 appeared to modify LA:AA in that G allele
carriers showed higher ratios compared to CC carriers (p¼0.002,
2 df test). In NC2, rs174575 was associated with lower AA con-
centrations with increasing number of variant alleles (p¼0.025).
There were no signiﬁcant associations between FADS genotype
and concentrations of EPA (Fig. 3), DHA or the ratio of ALA:EPA in
either cohort.
The genotype of the mothers was evaluated in relation to
neurodevelopmental outcomes in the children as shown in
Table 4. There were no signiﬁcant genetic associations between
FADS genotype and child developmental scores in either NC1 or
NC2. A non-signiﬁcant trend for infants of rs3834458 del carriers
to score higher on the Psychomotor Developmental Index (PDI)
was found in both NC1 and NC2 (p¼0.07 and 0.07 respectively).4. Discussion
We found in two high ﬁsh-eating observational mother-child
cohorts from the Republic of Seychelles that maternal FADS gen-
otype rs3834458 was signiﬁcantly associated with LC-PUFA status.
The strongest associations were observed for AA and the LA:AA
ratio, with variant homozygotes in the much larger cohort (NC2)
showing 20% lower AA and 42% higher LA:AA than those with the
homozygous reference genotype. These ﬁndings support prior
studies reporting that carriers of the minor alleles of FADS SNPs,
including rs3834458, tend to have a lower blood composition of
LC-PUFA, particularly of AA but also of EPA [16,29,42]. However, in
our study there was no association of rs3834458, or any other
FADS genotype, with either serum EPA or DHA composition. This
ﬁnding agrees with the majority of studies which have shown
DHA status to be less inﬂuenced by genetic variation in FADS genes
[11,16]. One plausible reason for this ﬁnding is that whilst the LC-
PUFA desaturation pathway mainly takes place within the endo-
plasmic reticulum, the ﬁnal conversion step from doc-
osapentaenoic acid (DPA; C22:5n-3) to DHA (partial β-oxidation)
requires a translocation to the peroxisomes [34]. This peroxisomalozygote Heterozygote Minor allele homozygote
(%)
31.1 GT 5.6 TT
16.1 TC 6.7 CC
28.2 Tdel 5.9 deldel
35.0 CG 5.1 GG
28.5 GT 3.6 TT
24.8 TC 3.1 CC
26.4 Tdel 3.2 deldel
33.3 CG 5.5 GG
for the different SNPs.
Table 3
Relative differences in PUFA concentrations (mg/ml) by FADS genotypes compared to the reference genotype in NC1 and NC2a,b,c.
SNP Cohort Genotype LA AA LA:AA ALA DHA EPA ALA:DHA ALA:EPA
FADS1-FADS2 rs3834458 NC1 TTd 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000
Tdel 1.054 0.922 1.142 1.243 1.019 1.004 1.259 1.122
Deldel 1.041 0.835 1.253 1.213 0.934 0.982 1.282 1.359
P-value 0.154 0.004 o0.001 0.133 0.915 0.970 0.165 0.256
NC2 TTd 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000
Tdel 1.044 0.933 1.106 1.011 1.019 1.014 0.987 1.000
Deldel 1.120 0.799 1.426 1.064 0.940 1.023 1.244 1.036
P-value 0.002 o0.001 o0.001 0.017 0.517 0.206 0.028 0.358
FADS2 rs174575 NC1 CCd 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000
CG 1.019 0.982 1.055 1.153 1.081 1.046 1.106 0.914
GG 1.075 0.858 1.260 0.931 0.949 0.979 0.941 0.961
P-value 0.399 0.118 0.002 0.393 0.664 0.538 0.694 0.743
NC2 CCd 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000
CG 1.024 0.988 1.036 1.002 1.000 1.001 1.002 1.001
GG 0.991 0.872 1.122 0.991 0.924 0.985 1.088 1.005
P-value 0.288 0.025 0.342 0.842 0.371 0.680 0.483 0.966
a NC1, Nutrition Cohort 1; NC2, Nutrition Cohort 2; LA, linoleic acid; AA, arachidonic acid; ALA, α-linolenic acid; del¼one base-pair deletion.
b We present relative difference in PUFA concentrations by genotype compared to the mean concentration in homozygote carriers of the reference genotype. Therefore
values greater than one show an average increase compared to the reference SNP and values less than one show an average decrease compared to the reference SNP. Bolded
P-values, derived from unadjusted ANOVA, identify groups that differ signiﬁcantly by genotype.
c rs3834458 is FADS1-FADS2 intergenic [25].
d Reference genotype.
Fig. 2. Prenatal arachidonic acid (AA; to compare the two cohorts we report the relative difference compared to the mean AA in carriers of the reference genotype). Boxplots
are shown for each genotype in both the NC1 and NC2 cohorts. Differences between the genotypes are signiﬁcant for all four SNPs in both cohorts except rs174575 in the NC1
cohort (see Table 3 and S3).
A.J. Yeates et al. / Prostaglandins, Leukotrienes and Essential Fatty Acids 102-103 (2015) 13–20 17conversion accounts for DHA being the least efﬁciently synthe-
sized n-3 LC-PUFA in the body and as a result, the impact of
genetic variation may be ‘diluted’ and less likely to inﬂuence DHA
status [17]. It could also be hypothesized that the reason for a lack
of genetic inﬂuence on DHA status shown in the current study
may be related to high ﬁsh consumption and subsequently higher
levels of preformed DHA in the population, which may mean
lower dependence on the endogenous synthesis pathway. This
hypothesis is supported by the recent study by Scholtz et al where
the inﬂuence of FADS genotype on DHA status became non-
signiﬁcant following ﬁsh oil supplementation among a groupwho had lower DHA status at baseline [32]. However, despite high
ﬁsh intake in our cohorts, some endogenous activity for produc-
tion of n-3 LC-PUFA might exist and thereby account for the higher
LA:AA found in both cohorts and higher ALA:DHA found in NC2. A
recent randomized controlled trial of ﬁsh oil supplementation
reported that increased dietary intakes of EPA and DHA were
associated with higher activity of Δ5D and lower activity of Δ6D
[1]. These ﬁndings may suggest that the endogenous LC-PUFA
synthesis pathway remains active, and perhaps enhanced, despite
abundant preformed LC-PUFA in the diet. However we must
acknowledge that the ALA:DHA ratio is limited as an indicator of
Fig. 3. Prenatal Eicosapentaenoic acid (EPA; to compare the two cohorts we report the relative difference compared to the mean EPA in carriers of the reference genotype).
Boxplots are shown for each genotype in both the NC1 and NC2 cohorts. Differences between the genotypes are not signiﬁcant for either cohort or any SNP (see Table 3 and S3).
Table 4
Relative differences in child developmental scores by mother's genotype compared to the reference genotype from linear regression modelsa,b,c.
BSID-II Outcome/SNP Genotype NC1 BSID-II scores NC2 BSID-II scores
n Relative mean 95% CI P n Relative mean 95% CI P
MDI TTd 145 1.00 (0.982,1.018) 0.06 924 1.00 (0.992,1.008) 0.18
FADS1-FADS2 rs3834458 Tdel 61 1.02 (0.996,1.051) 343 1.01 (1.000,1.025)
Deldel 13 1.01 (0.951,1.069) 39 1.01 (0.972,1.046)
MDI CCd 127 1.00 (0.981,1.019) 0.88 800 1.00 (0.992,1.008) 0.50
FADS2 rs174575 CG 75 1.01 (0.982,1.030) 437 1.01 (0.996,1.018)
GG 11 1.01 (0.944,1.071) 68 1.01 (0.984,1.040)
PDI TTd 143 1.00 (0.975,1.025) 0.07 923 1.00 (0.993,1.007) 0.06
FADS1-FADS2 rs3834458 Tdel 60 1.04 (1.001,1.078) 342 1.02 (1.004,1.027)
Deldel 13 1.04 (0.961,1.124) 39 1.02 (0.985,1.053)
PDI CCd 126 1.00 (0.974,1.026) 0.91 798 1.00 (0.992,1.008) 0.69
FADS2 rs174575 CG 74 1.01 (0.972,1.039) 435 1.01 (0.996,1.017)
GG 11 1.00 (0.916,1.091) 70 1.00 (0.973,1.024)
a NC1, Nutrition Cohort 1; NC2, Nutrition Cohort 2; del¼one base-pair deletion; BSID-II, Bayley Scales of Infant Development II; MDI, Mental Developmental Index; PDI,
psychomotor developmental index.
b β Coefﬁcients, 95% CI and P values presented are from linear regression models adjusted for child sex, maternal age at delivery, presence of two parents in the
household, socioeconomic status, and birth weight (for NC1) or child age at testing (NC2). P-values are from the 2 df tests comparing the 3 levels of each genotype.
c rs3834458 is FADS1-FADS2 intergenic (NCBI) [25].
d Reference genotype.
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which occurs from ALA endogenously. We also cannot clearly
differentiate which of the SNPs is related to the LC-PUFA pheno-
type, as there is strong linkage for the FADS1 SNPs and the FADS1-
FADS2 intergenic rs3834458. However, a less pronounced asso-
ciation was found for FADS2 rs174575 compared to the FADS1
SNPs, which could suggest that the functional association is rela-
ted to differences in Δ5D rather than Δ6D activities, but we
cannot exclude the potential inﬂuence of other genes in the LC-
PUFA pathway.
The maternal FADS genotype was not signiﬁcantly associated
with infant development in either cohort. However, we did ﬁnd atrend for improved psychomotor development among infants of
mothers with the variant allele for rs3834458 in both NC1
(p¼0.07) and NC2 (p¼0.07). This suggests a subtle association of
the FADS genotype with neurodevelopment, even at high ﬁsh
intake. We suspect, from the lack of associations between
rs3834458 and EPA or DHA, that this trend might be related to
lower production of AA, which is a precursor for pro-inﬂammatory
eicosanoids [15]. Data from the English mother–child ALSPAC
cohort, also found children of mothers with the rs3834458 minor
allele performed better in tests of intelligence quotient at 8 years
[35]. In our recent analysis of the associations between maternal
PUFA status and neurodevelopment in NC2, we found no direct
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However, we did ﬁnd signiﬁcant adverse associations between
higher maternal n-6/n-3 ratios and both infant psychomotor
development and communicative ability at 20 months of age. This
suggests that the balance between AA and DHA may be important
for neurodevelopment and a possible mechanism would be
through inﬂuencing the inﬂammatory milieu [38].
Recent studies suggest that the interaction between PUFA and
genetic variability is complex. One recent study suggests that n-3
LC-PUFA supplementation can induce epigenetic regulation of
FADS genes and genes encoding the elongase enzymes, ELOVL5
and ELOVL2, in a sex-speciﬁc manner [13]. If true, this regulation
may explain why different populations, with similar allelic fre-
quencies of FADS SNPs but with distinct diets, may present health
disparities [21]. Future studies may need to consider genetic var-
iation in genes controlling eicosanoid synthesis from LC-PUFA,
such as 5-lipoxygenase (ALOX5) [21]. Taken together, these data
provide a ﬁrm basis for considering each population group sepa-
rately in studies of FADS and PUFA status.
There are some methodological issues to consider with the
current study. The processing time of the blood collected was
different between the two cohorts, and may partially explain the
different serum concentrations of LC-PUFA reported [37]. How-
ever, to compensate for this and make the cohorts more compar-
able, we scaled PUFA values in each cohort to the estimated mean
concentration in homozygote carriers of the reference genotype, as
described [27,28]. We included developmental testing points in
the two cohorts that were reasonably close in age (30 months in
NC1 and 20 months in NC2) to enhance comparability. Average
MDI scores across the cohorts were similar whereas PDI scores
were greater in the NC2 cohort, possibly owing to the younger age
at examination. We further included similar a priori covariates in
the regression analysis to increase comparability of associations
across cohorts. We observed relatively consistent genetic associa-
tions in the two cohorts, but fewer were statistically signiﬁcant in
the NC1 cohort, perhaps owing to the smaller sample size. We
acknowledge that the precursor:product PUFA ratios are limited as
markers of enzyme activity. However, these ratios have been used
frequently for this purpose and we believe that our use of serum
absolute PUFA concentrations in denoting these ratios is a strength
of the current study.
In conclusion, we found that the maternal FADS genotype is
an important predictor of maternal AA, but not of EPA and DHA
status. To our knowledge this is the ﬁrst time that such asso-
ciations have been described within a high ﬁsh-eating cohort.
These results highlight the importance of considering FADS
genotype, even at high ﬁsh intake, to aid understanding asso-
ciations between maternal LC-PUFA status, ﬁsh consumption and
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